National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 15856 [2018-07611]

Download as PDF 15856 Federal Register / Vol. 83, No. 71 / Thursday, April 12, 2018 / Notices Dated: April 9, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; NIA Clinical Trials. Date: May 17, 2018. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Maurizio Grimaldi, MD, Ph.D., Scientific Review Officer, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Room 2C218, Bethesda, MD 20892, 301–496–9374, grimaldim2@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: April 9, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HOMELAND SECURITY National Institutes of Health U.S. Customs and Border Protection National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting [FR Doc. 2018–07609 Filed 4–11–18; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES U.S. Immigration and Customs Enforcement Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Planning Grant (R34). Date: May 3, 2018. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Chelsea D. Boyd, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC–9823, Rockville, MD 20852–9834, 240–669–2081, chelsea.boyd@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 9, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–07611 Filed 4–11–18; 8:45 am] BILLING CODE 4140–01–P U.S. Customs and Border Protection (CBP) and U.S. Immigration and Customs Enforcement (ICE), Department of Homeland Security. AGENCY: ACTION: General notice; correction. CBP and ICE published a document in the Federal Register of February 16, 2018, concerning the process to solicit, evaluate, and select interested parties in the private sector to fulfill agency needs for instruction and related instructional materials for traderelated training, pursuant to section 104 of the Trade Facilitation and Trade Enforcement Act of 2015. The document contained incorrect contact information. SUMMARY: This correction is effective April 12, 2018. DATES: FOR FURTHER INFORMATION CONTACT: Keith Josephson, Trade Transformation Office, U.S. Customs & Border Protection, at 571–468–5108. Correction In the Federal Register of February 16, 2018, in FR Doc. 2018–03233, on page 7064, in the first column, correct the FOR FURTHER INFORMATION CONTACT caption to read: FOR FURTHER INFORMATION CONTACT: Questions should be addressed to agency-designated personnel below: CBP: Keith Josephson (571–468–5108). ICE: Special Agent Nadine Andrews (703– 603–3955). All other information contained in the notice remains unchanged. Dated: April 9, 2018. Alice A. Kipel, Executive Director, Regulations and Rulings, Office of Trade, U.S. Customs and Border Protection. [FR Doc. 2018–07610 Filed 4–11–18; 8:45 am] sradovich on DSK3GMQ082PROD with NOTICES Announcement of Program for the Private Sector To Participate in TradeRelated Training of U.S. Customs and Border Protection and U.S. Immigration and Customs Enforcement Personnel; Correction BILLING CODE 4140–01–P [FR Doc. 2018–07581 Filed 4–11–18; 8:45 am] BILLING CODE 9111–14–P VerDate Sep<11>2014 19:20 Apr 11, 2018 Jkt 244001 PO 00000 Frm 00073 Fmt 4703 Sfmt 9990 E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 83, Number 71 (Thursday, April 12, 2018)]
[Notices]
[Page 15856]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07611]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning Grant 
(R34).
    Date: May 3, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Chelsea D. Boyd, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers 
Lane, MSC-9823, Rockville, MD 20852-9834, 240-669-2081, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 9, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07611 Filed 4-11-18; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.